Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Foghorn Therapeutics (United States) | Researchclopedia

Back to institutions

Foghorn Therapeutics (United States)

Cambridge, Massachusettscompany

102

Works

9,488

Citations

61

h-index

Top Research Topics

Protein Degradation and Inhibitors Chromatin Remodeling and Cancer Acute Myeloid Leukemia Research

Top Researchers

M Snyder Cardiovascular Institute of the South

3,250 works199,987 citationsh-index: 210

Recent Research

THE ECONOMIC IMPACT OF MANAGING INVASIVE ASPERGILLOSIS IN BRAZILIAN PRIVATE HEALTHCARE: A COMPARATIVE ANALYSIS BETWEEN ISAVUCONAZOLE AND VORICONAZOLE

Frederico Silva Valentim Sallum

20260 citations

Cancer Mechanisms and Therapy

Genomics and Chromatin Dynamics

Histone Deacetylase Inhibitors Research

Mechanisms of cancer metastasis

Ubiquitin and proteasome pathways

Epigenetics and DNA Methylation

Peptidase Inhibition and Analysis

Sarcoma Diagnosis and Treatment

RNA Research and Splicing

Daniel J. Brat Northwestern University

808 works88,936 citationsh-index: 111

Neil J. Sebire Great Ormond Street Hospital

1,585 works47,824 citationsh-index: 102

David C.S. Huang The University of Melbourne

575 works45,424 citationsh-index: 101

Leslie G. Biesecker National Institutes of Health

556 works39,285 citationsh-index: 103

William C. Faquin Massachusetts Eye and Ear Infirmary

806 works36,484 citationsh-index: 83

Overcoming Menin inhibitor resistance in AML cells with combinations including BET proteins and dual BRG1/BRM inhibitor

Warren Fiskus,Christopher P. Mill,et al.

20260 citations

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high‐risk MECOM‐rearranged AML

Warren Fiskus,Christopher P. Mill,et al.

20260 citations

Prognostic Implications of <scp> <i>SMARCA4</i> </scp> , <scp> <i>ARID1A</i> </scp> , and Other <scp>BAF</scp> Mutations in Non‐Small Cell Lung Cancer

Alexis Khalil,Michael P. Collins,et al.

20251 citations

Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers

Richard C. Centore,Luis M. M. Soares,et al.

20251 citations

Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers

Richard C. Centore,Luis M. M. Soares,et al.

20250 citations